314 related articles for article (PubMed ID: 18177830)
21. The future of prenatal diagnosis: rapid testing or full karyotype? An audit of chromosome abnormalities and pregnancy outcomes for women referred for Down's Syndrome testing.
Ogilvie CM; Lashwood A; Chitty L; Waters JJ; Scriven PN; Flinter F
BJOG; 2005 Oct; 112(10):1369-75. PubMed ID: 16167939
[TBL] [Abstract][Full Text] [Related]
22. Fitting observed and theoretical choices - women's choices about prenatal diagnosis of Down syndrome.
Seror V
Health Econ; 2008 May; 17(5):557-77. PubMed ID: 17806133
[TBL] [Abstract][Full Text] [Related]
23. Periconceptional exposure to contraceptive pills and risk for Down syndrome.
Martínez-Frías ML; Bermejo E; Rodríguez-Pinilla E; Prieto L
J Perinatol; 2001; 21(5):288-92. PubMed ID: 11536021
[TBL] [Abstract][Full Text] [Related]
24. Beyond race or ethnicity and socioeconomic status: predictors of prenatal testing for Down syndrome.
Kuppermann M; Learman LA; Gates E; Gregorich SE; Nease RF; Lewis J; Washington AE
Obstet Gynecol; 2006 May; 107(5):1087-97. PubMed ID: 16648415
[TBL] [Abstract][Full Text] [Related]
25. Long-term trends for socio-economic differences in prenatal diagnosis of Down syndrome: diffusion of services or persistence of disparities?
Khoshnood B; De Vigan C; Blondel B; Vodovar V; Cadio E; Goffinet F
BJOG; 2008 Aug; 115(9):1087-95. PubMed ID: 18518869
[TBL] [Abstract][Full Text] [Related]
26. Knowledge of prenatal screening and psychological management of test decisions.
Dahl K; Hvidman L; Jørgensen FS; Kesmodel US
Ultrasound Obstet Gynecol; 2011 Aug; 38(2):152-7. PubMed ID: 20954167
[TBL] [Abstract][Full Text] [Related]
27. The maternal self in pregnant women undergoing maternal serum screening.
Chiang HH; Chao YM; Yuh YS
J Clin Nurs; 2007 Jun; 16(6):1180-5. PubMed ID: 17518893
[TBL] [Abstract][Full Text] [Related]
28. Women and health care professionals' preferences for Down's Syndrome screening tests: a conjoint analysis study.
Bishop AJ; Marteau TM; Armstrong D; Chitty LS; Longworth L; Buxton MJ; Berlin C
BJOG; 2004 Aug; 111(8):775-9. PubMed ID: 15270923
[TBL] [Abstract][Full Text] [Related]
29. Costs and effects of prenatal screening methods for Down syndrome and neural tube defects.
Hoogendoorn M; Evers SM; Schielen PC; van Genugten ML; de Wit GA; Ament AJ
Community Genet; 2008; 11(6):359-67. PubMed ID: 18690004
[TBL] [Abstract][Full Text] [Related]
30. Congenital anomalies: parents' anxiety and women's concerns before prenatal testing and women's opinions towards the risk factors.
Sahin NH; Gungor I
J Clin Nurs; 2008 Mar; 17(6):827-36. PubMed ID: 18279286
[TBL] [Abstract][Full Text] [Related]
31. Maternal decision to terminate pregnancy in case of Down syndrome.
Korenromp MJ; Page-Christiaens GC; van den Bout J; Mulder EJ; Visser GH
Am J Obstet Gynecol; 2007 Feb; 196(2):149.e1-11. PubMed ID: 17306660
[TBL] [Abstract][Full Text] [Related]
32. Maternal, obstetric variables, perceived stress and health-related quality of life among pregnant women in Macao, China.
Lau Y; Yin L
Midwifery; 2011 Oct; 27(5):668-73. PubMed ID: 20466467
[TBL] [Abstract][Full Text] [Related]
33. Prenatal screening for Down syndrome: women's involvement in decision-making and their attitudes to screening.
Seror V; Ville Y
Prenat Diagn; 2009 Feb; 29(2):120-8. PubMed ID: 19123253
[TBL] [Abstract][Full Text] [Related]
34. Health behaviour modelling for prenatal diagnosis in Australia: a geodemographic framework for health service utilisation and policy development.
Muggli EE; McCloskey D; Halliday JL
BMC Health Serv Res; 2006 Sep; 6():109. PubMed ID: 16945156
[TBL] [Abstract][Full Text] [Related]
35. Recurrences of free trisomy 21: analysis of data from the National Down Syndrome Cytogenetic Register.
Morris JK; Mutton DE; Alberman E
Prenat Diagn; 2005 Dec; 25(12):1120-8. PubMed ID: 16231400
[TBL] [Abstract][Full Text] [Related]
36. Nuchal translucency screening: how do women actually utilize the results?
Caughey AB; Musci TJ; Belluomini J; Main D; Otto C; Goldberg J
Prenat Diagn; 2007 Feb; 27(2):119-23. PubMed ID: 17152116
[TBL] [Abstract][Full Text] [Related]
37. Screening options for Down syndrome: how women choose in real clinical setting.
Lo TK; Lai FK; Leung WC; Lau WL; Ng LS; Wong WC; Tam SS; Yee YC; Choi H; Lam HS; Sham AS; Tang LC; Chin RK
Prenat Diagn; 2009 Sep; 29(9):852-6. PubMed ID: 19441088
[TBL] [Abstract][Full Text] [Related]
38. An evaluation of the decision-making process regarding amniocentesis following a screen-positive maternal serum screen result.
Kobelka C; Mattman A; Langlois S
Prenat Diagn; 2009 May; 29(5):514-9. PubMed ID: 19242922
[TBL] [Abstract][Full Text] [Related]
39. The impact of first-trimester screening on AMA patients' uptake of invasive testing.
Wray AM; Ghidini A; Alvis C; Hodor J; Landy HJ; Poggi SH
Prenat Diagn; 2005 May; 25(5):350-3. PubMed ID: 15906421
[TBL] [Abstract][Full Text] [Related]
40. Decision making following a prenatal diagnosis of Down syndrome: an integrative review.
Choi H; Van Riper M; Thoyre S
J Midwifery Womens Health; 2012; 57(2):156-64. PubMed ID: 22432488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
